Vanguard Asset Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$68.9M Buy
798,007
+56,079
+8% +$4.67M 0.04% 344
2026
Q2
$50M Buy
741,928
+71,425
+11% +$4.76M 0.03% 409
2026
Q1
$42.1M Buy
+670,503
New +$46.7M 0.04% 401

Other funds holding DXCM

Vanguard Asset Management's DXCM Position: Q3 2026 in Review

Vanguard Asset Management increased its DexCom (DXCM) stake by 7.6% in Q3 2026, buying an estimated $4.67M and bringing the position to 798,007 shares worth $68.9M. The position accounts for 0.04% of the portfolio, ranked #344.

Vanguard Asset Management first reported a position in DXCM in Q1 2026 and has held it in 3 quarters since. 1,049 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

  • Vanguard Asset Management held 798,007 shares of DexCom worth $68.9M as of Q3 2026.
  • Vanguard Asset Management bought 56,079 DexCom shares in Q3 2026, an estimated $4.67M.
  • DexCom made up 0.04% of Vanguard Asset Management's portfolio in Q3 2026, its #344 holding.
  • Vanguard Asset Management first reported a position in DexCom in Q1 2026 and has held it in 3 quarters since.
  • 1,049 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on Vanguard Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.